Odronextamab is a humanized IgG4 bispecific antibody engineered to target CD20 on B cells and CD3 on T cells. This dual specificity facilitates the direct engagement of T cells and malignant B cells, promoting potent anti-tumor responses. Primarily designed for oncology research, Odronextamab holds significant potential for elucidating the mechanisms of T cell-mediated cytotoxicity in B cell malignancies.
Odronextamab is a humanized IgG4 bispecific antibody engineered to target CD20 on B cells and CD3 on T cells. This dual specificity facilitates the direct engagement of T cells and malignant B cells, promoting potent anti-tumor responses. Primarily designed for oncology research, Odronextamab holds significant potential for elucidating the mechanisms of T cell-mediated cytotoxicity in B cell malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
